Soriot should explain the curious case of AstraZeneca’s non-deal

▶ Guardian Business Aug 5, 2026 Aug 5 👁 1 views

📋 Article Summary

83 words

AstraZeneca’s rumoured takeover of Bristol Myers Squibb already looked weird, and was met with a lack of enthusiasm by shareholdersAstraZeneca falls to third-largest UK company amid US merger talksHold the heartburn pills. It seems AstraZeneca is no longer contemplating a… AstraZeneca’s rumoured takeover of Bristol Myers Squibb already looked weird, and was met with a lack of enthusiasm by shareholdersAstraZeneca falls to third-largest UK company amid US merger talksHold the heartburn pills. It seems AstraZeneca is no longer contemplating a…

ⓘ Summary only. Read the complete story on Guardian Business below.

Full story on Guardian Business

Read Full Article →

🔗 You will be taken to www.theguardian.com

► Necessary Cookies Always Active

Necessary cookies enable essential site features like secure log-ins and consent preference adjustments. They do not store personal data.

► Functional Cookies Remark

Functional cookies support features like content sharing on social media, collecting feedback, and enabling third-party tools.

► Analytical Cookies Remark

Analytical cookies track visitor interactions, providing insights on metrics like visitor count, bounce rate, and traffic sources.

► Advertisement Cookies Remark

Advertisement cookies deliver personalized ads based on your previous visits and analyze the effectiveness of ad campaigns.